Eric D. Mintz

Eric D. Mintz

Auto-generated profile, based on publicly available information

Eric D. Mintz

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2010 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JCJohn A. Crump
John A. Crump
EMEric D. Mintz
Eric D. Mintz
Typhoid and paratyphoid fever continue to be important causes of illness and death, particularly among children and adolescents in south-central and

1 May 2004 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
SOSonja J. Olsen
Sonja J. Olsen
JPJim Pruckler
Jim Pruckler
WBWilliam Bibb
William Bibb
NTNguyen Thi My Thanh
Nguyen Thi My Thanh
TTTran My Trinh
Tran My Trinh
EMEric D. Mintz
Eric D. Mintz
Laboratory diagnosis of typhoid fever requires isolation and identification of Salmonella enterica serotype Typhi. In many areas where this disease is endemic, laboratory capability is limited. Recent advances in molecular immunology have led to the identification of sensitive and specific markers for typhoid fever and technology to manufacture practical and inexpensive kits for their rapid detection. We evaluated three commercial kits for serologic diagnosis of typhoid fever. Patients presenting with ≥ 4 days of fever were enrolled at two hospitals in Southern Vietnam. Cases were patients with serotype Typhi isolated from blood samples, and controls were patients with other laboratory-confirmed illnesses. Serotype Typhi isolates were confirmed and tested for antimicrobial susceptibility at the Pasteur Institute in Ho Chi Minh City. The Widal test was run at the hospitals and the Pasteur Institute. Sera were shipped frozen to the Centers for Disease Control and Prevention and tested by using Multi-Test Dip-S-Ticks, TyphiDot, and TUBEX to detect immunoglobulin G (IgG), IgG and IgM, and IgM, respectively. Package insert protocol instructions were followed. We enrolled 59 patients and 21 controls. The sensitivity and specificity findings were as follows: 89 and 53% for Multi-Test Dip-S-Ticks, 79 and 89% for TyphiDot, 78 and 89% for TUBEX, and 64 and 76% for Widal testing in hospitals and 61% and 100% for Widal testing at the Pasteur Institute. For all assays, the sensitivity was highest in the second week of illness. The Widal test was insensitive and displayed interoperator variability. Two rapid kits, TyphiDot and TUBEX, demonstrated promising results.

15 May 2004 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
AGAmita Gupta
Amita Gupta
CPChristina S. Polyak
Christina S. Polyak
RBRichard D. Bishop
Richard D. Bishop
JSJeremy Sobel
Jeremy Sobel
EMEric D. Mintz
Eric D. Mintz
During 1989–2002, a total of 208,368 laboratory-confirmed Shigella infections were reported to the Centers for Disease Control and Prevention. Shigel

6 September 2018 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
ARAmruta Radhakrishnan
Amruta Radhakrishnan
DADaina Als
Daina Als
EMEric D. Mintz
Eric D. Mintz
JCJohn A. Crump
John A. Crump
JSJefferey Stanaway
Jefferey Stanaway
ZBZulfiqar Bhutta
Zulfiqar Bhutta
This article is the introduction to a 12-paper supplement on global trends in typhoid fever. The Tackling Typhoid (T2) project was initiated in 2015 to synthesize the existing body of literature on typhoidal salmonellae and study national and regional typhoid fever trends. In addition to a global systematic review, eight case studies were undertaken to examine typhoid and paratyphoid fever trends in endemic countries alongside changes in relevant contextual factors. Incidence variations exist both within and between regions with large subnational differences as well, suggesting that public health changes impacting typhoid and paratyphoid fevers in one setting may not have similar impacts in another. This supplement also brings to light the lack of national typhoid fever surveillance systems, inconsistencies in diagnostics, and the lack of typhoid fever associated morbidity and mortality data in many countries, making it difficult to accurately quantify and track burden of disease. To better understand typhoid fever there is a need for more high-quality data from resource-poor settings. The implementation of typhoid surveillance systems alongside the transition to blood-culture confirmation of cases, where possible, would aid in the improvement of data quality in low-income settings. The following supplement includes the results of our global systematic review, eight-country case study articles, a qualitative article informed by semistructured interviews, and a conclusion article on potential ways forward for typhoid control.

5 January 2017 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SKSteven Ndugwa Kabwama
Steven Ndugwa Kabwama
LBLilian Bulage
Lilian Bulage
FNFred Nsubuga
Fred Nsubuga
GPGerald Pande
Gerald Pande
DODavid Were Oguttu
David Were Oguttu
BZBao-Ping Zhu
Bao-Ping Zhu
On 6 February 2015, Kampala city authorities alerted the Ugandan Ministry of Health of a “strange disease” that killed one person and sickened dozens. We conducted an epidemiologic investigation to identify the nature of the disease, mode of transmission, and risk factors to inform timely and effective control measures. We defined a suspected case as onset of fever (≥37.5 °C) for more than 3 days with abdominal pain, headache, negative malaria test or failed anti-malaria treatment, and at least 2 of the following: diarrhea, nausea or vomiting, constipation, fatigue. A probable case was defined as a suspected case with a positive TUBEX® TF test. A confirmed case had blood culture yielding Salmonella Typhi. We conducted a case-control study to compare exposures of 33 suspected case-patients and 78 controls, and tested water and juice samples. From 17 February–12 June, we identified 10,230 suspected, 1038 probable, and 51 confirmed cases. Approximately 22.58% (7/31) of case-patients and 2.56% (2/78) of controls drank water sold in small plastic bags (ORM-H = 8.90; 95%CI = 1.60–49.00); 54.54% (18/33) of case-patients and 19.23% (15/78) of controls consumed locally-made drinks (ORM-H = 4.60; 95%CI: 1.90–11.00). All isolates were susceptible to ciprofloxacin and ceftriaxone. Water and juice samples exhibited evidence of fecal contamination. Contaminated water and street-vended beverages were likely vehicles of this outbreak. At our recommendation authorities closed unsafe water sources and supplied safe water to affected areas.

1 April 2000 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
NDNicholas A. Daniels
Nicholas A. Daniels
JNJakob Neimann
Jakob Neimann
AKAdam Karpati
Adam Karpati
UPUmesh D. Parashar
Umesh D. Parashar
KGKatherine D. Greene
Katherine D. Greene
RQRobert Quick
Robert Quick
Enterotoxigenic Escherichia coli (ETEC) has become the leading bacterial cause of gastroenteritis outbreaks on cruise ships. Investigation of recent